BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

Impossible to say. Novartis was already in that space. All they...

  1. Hoyland
    4,015 Posts.
    lightbulb Created with Sketch. 127
    clock Created with Sketch.
    11/04/18
    14:26
    Post #: 32378758
    Impossible to say. Novartis was already in that space. All they have done is buy a competitor.

    I am not aware of any big pharma working in the OPMD space. I think we have no competition, which is both a pro and a con. If get through our trial successfully, I can see interest heating up but that is some way off.
    BLT Price at posting: 20.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.